A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
Status:
Completed
Trial end date:
2018-10-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and efficacy of ALN-PCSSC in
participants with homozygous familial hypercholesterolemia.